Position in TKNO
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,011
+$182 QoQ
Shares Held
1,734
+36.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in TKNO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. TKNO ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
578,753 | $68,414,382 | |
| 2 | VTRS |
Viatris Inc
|
3,347,591 | $45,225,949 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
67,551 | $40,056,384 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
219,755 | $28,950,515 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
645,037 | $15,435,730 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
393,588 | $11,854,866 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
193,436 | $10,698,942 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
138,941 | $10,684,560 |
All Filings in TKNO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,011 | 1,734 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,829 | 1,271 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,793 | 936 | Shares | Defined | 2025-11-13 | |
| 2022-09-30 | $656,185 | 196,463 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $1,655,068 | 197,032 | Shares | Defined | 2022-07-29 | |
| 2021-12-31 | $4,173,864 | 203,802 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $4,515,369 | 181,413 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $396,812 | 16,722 | Shares | Defined | 2021-08-04 | |
| No filing history on record for this holder in this stock. | ||||||